Veracyte Inc (VCYT)
19.48
-0.42
(-2.11%)
USD |
NASDAQ |
Apr 25, 16:00
19.48
0.00 (0.00%)
After-Hours: 20:00
Veracyte Cash from Operations (TTM): 44.22M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 44.22M |
September 30, 2023 | 38.41M |
June 30, 2023 | 31.27M |
March 31, 2023 | 14.24M |
December 31, 2022 | 7.535M |
September 30, 2022 | 6.237M |
June 30, 2022 | -2.182M |
March 31, 2022 | 0.068M |
December 31, 2021 | -31.62M |
September 30, 2021 | -37.81M |
June 30, 2021 | -34.66M |
March 31, 2021 | -44.97M |
December 31, 2020 | -9.711M |
September 30, 2020 | -10.18M |
June 30, 2020 | -13.49M |
March 31, 2020 | -7.522M |
December 31, 2019 | -3.232M |
September 30, 2019 | -6.248M |
June 30, 2019 | -6.475M |
March 31, 2019 | -7.119M |
December 31, 2018 | -13.52M |
Date | Value |
---|---|
September 30, 2018 | -18.11M |
June 30, 2018 | -21.43M |
March 31, 2018 | -23.24M |
December 31, 2017 | -23.92M |
September 30, 2017 | -22.33M |
June 30, 2017 | -24.67M |
March 31, 2017 | -27.47M |
December 31, 2016 | -27.98M |
September 30, 2016 | -26.58M |
June 30, 2016 | -22.94M |
March 31, 2016 | -26.70M |
December 31, 2015 | -26.96M |
September 30, 2015 | -32.57M |
June 30, 2015 | -35.30M |
March 31, 2015 | -29.74M |
December 31, 2014 | -27.63M |
September 30, 2014 | -22.49M |
June 30, 2014 | -21.20M |
March 31, 2014 | -19.30M |
December 31, 2013 | -19.16M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-44.97M
Minimum
Mar 2021
44.22M
Maximum
Dec 2023
-3.480M
Average
-6.248M
Median
Sep 2019
Cash from Operations (TTM) Benchmarks
Fonar Corp | 15.29M |
XWELL Inc | -16.07M |
ProPhase Labs Inc | -11.35M |
Applied DNA Sciences Inc | -7.592M |
OncoCyte Corp | -23.32M |